Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 1/2009

01.02.2009 | BH4 and PKU

PKU—What is daily practice in various centres in Europe?

Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders

verfasst von: F. J. van Spronsen, K. Kiær Ahring, M. Gizewska

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Summary

Background:

Since the start of the European Society of Phenylketonuria and Allied Disorders Treated as Phenylketonuria (ESPKU) in 1987, an increasing number of parental organizations of member countries have joined. Treatment varies widely within Europe. A survey among professionals was done to determine goals and practice.

Method:

In 2005, a questionnaire was sent to professionals of member countries, addressing diagnostic and treatment procedures, numbers of patients necessary for a PKU centre, guidelines followed, numbers of patients treated and professionals involved in care, target phenylalanine concentrations, amount of protein prescribed, frequency of monitoring and clinical visits, need for follow-up of various clinical and biochemical data, the importance of various abnormalities, and definition of (non)compliance.

Results:

Seventeen centres of 12 countries answered. Professionals of 13 countries could not be reached or did not respond. Differences in care were observed in many issues of care including target phenylalanine concentrations. Only few issues had general consensus.

Conclusion:

Not all countries were really active at ESPKU level. In the active countries, a professional could not always be contacted. Responses show that PKU care varies largely between European countries. Notwithstanding the large diversity on many issues of day-to-day care and therapeutic targets, results showed increasing consensus on some issues. The most important outcome of this questionnaire might be that the Scientific Advisory Committee of the ESPKU initiated meetings for professionals of different backgrounds taking care of PKU patients besides the already existing programme for parents, patients and delegates. Discussion among these professionals may improve quality of care.
Literatur
Zurück zum Zitat Burgard P, Bremer HJ, Bührdel P, et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria. Eur J Pediat 158: 46–54. doi:10.1007/s004310051008.CrossRef Burgard P, Bremer HJ, Bührdel P, et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria. Eur J Pediat 158: 46–54. doi:10.​1007/​s004310051008.CrossRef
Zurück zum Zitat MRC (1993a) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria. BMJ 306: 115–119.CrossRef MRC (1993a) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria. BMJ 306: 115–119.CrossRef
Zurück zum Zitat MRC (1993b) Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria. Arch Dis Child 68: 426–427.CrossRef MRC (1993b) Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria. Arch Dis Child 68: 426–427.CrossRef
Zurück zum Zitat Schweitzer-Krantz S, Burgard P (2000) Survey of national guidelines for the treatment of phenylketonuria. Eur J Pediatr 159(Supplement 2): S70–73.PubMedCrossRef Schweitzer-Krantz S, Burgard P (2000) Survey of national guidelines for the treatment of phenylketonuria. Eur J Pediatr 159(Supplement 2): S70–73.PubMedCrossRef
Zurück zum Zitat Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis 31: 673–679.PubMedCrossRef Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis 31: 673–679.PubMedCrossRef
Metadaten
Titel
PKU—What is daily practice in various centres in Europe?
Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders
verfasst von
F. J. van Spronsen
K. Kiær Ahring
M. Gizewska
Publikationsdatum
01.02.2009
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 1/2009
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-008-0966-y

Weitere Artikel der Ausgabe 1/2009

Journal of Inherited Metabolic Disease 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.